ALNYLAM PHARMACEUTICALS (ALNY) Covered Calls

ALNYLAM PHARMACEUTICALS covered calls Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing & regulating the expression of specific genes.

You can sell covered calls on ALNYLAM PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALNY (prices last updated Fri 4:16 PM ET):

ALNYLAM PHARMACEUTICALS (ALNY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
76.65 -1.94 76.35 76.65 967K - 7.9B
Covered Calls For ALNYLAM PHARMACEUTICALS (ALNY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 75 5.50 71.15 5.4% 68.0%
Dec 21 75 6.90 69.75 7.5% 42.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.